Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China · Delayed Price · Currency is CNY 12.70
-0.28 (-2.16%)
Jun 11, 2026, 3:04 PM CST
SHE:002275 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 452.67 | 433.13 | 521.53 | 421.3 | 329.53 | 343.72 |
Depreciation & Amortization | 96.2 | 96.2 | 110.08 | 115.12 | 114.83 | 106.72 |
Other Amortization | 11.64 | 11.64 | 16.4 | 9.61 | 9.21 | 6.27 |
Loss (Gain) From Sale of Assets | -0.15 | -0.15 | -83.35 | -1.67 | -31.24 | -15.12 |
Asset Writedown & Restructuring Costs | 0.73 | 0.73 | 0.85 | 0.16 | 1 | 7.74 |
Loss (Gain) From Sale of Investments | -13.83 | -13.83 | -10.84 | -6.73 | -5.87 | -9.65 |
Provision & Write-off of Bad Debts | 22.85 | 22.85 | 9.22 | 0.01 | 3.91 | 1.28 |
Other Operating Activities | -35.5 | 23.56 | 26.97 | 16.73 | 8.71 | 18.05 |
Change in Accounts Receivable | 216.7 | 216.7 | -71.56 | 72.95 | -88.25 | -66.83 |
Change in Inventory | -13.12 | -13.12 | 20.54 | -27.23 | 33.67 | -99.73 |
Change in Accounts Payable | -72.53 | -72.53 | 46.36 | -80.35 | 84.98 | 120.16 |
Change in Other Net Operating Assets | - | - | 2.85 | 30.48 | 65.78 | - |
Operating Cash Flow | 668.6 | 708.12 | 588.33 | 549.25 | 528.67 | 410.24 |
Operating Cash Flow Growth | 9.79% | 20.36% | 7.12% | 3.89% | 28.87% | -31.40% |
Capital Expenditures | -83.76 | -86.94 | -82.18 | -76.4 | -62.27 | -144.09 |
Sale of Property, Plant & Equipment | -0.71 | 0.06 | 0.46 | 53.69 | 2.75 | 27.73 |
Investment in Securities | -325.29 | -318.61 | -246.22 | 473.49 | 957.69 | -39.94 |
Other Investing Activities | -73.99 | -23.72 | -21.48 | -545.01 | -978.43 | 9.33 |
Investing Cash Flow | -483.75 | -429.21 | -349.41 | -94.22 | -80.24 | -146.97 |
Long-Term Debt Issued | - | 355 | 476.7 | 410.7 | 159.7 | 276.68 |
Total Debt Issued | 208.09 | 355 | 476.7 | 410.7 | 159.7 | 276.68 |
Long-Term Debt Repaid | - | -445.13 | -398.98 | -354.24 | -315.71 | -192.87 |
Total Debt Repaid | -441.59 | -445.13 | -398.98 | -354.24 | -315.71 | -192.87 |
Net Debt Issued (Repaid) | -233.51 | -90.13 | 77.72 | 56.46 | -156.01 | 83.81 |
Issuance of Common Stock | - | - | - | - | 84.1 | - |
Common Dividends Paid | -340.13 | -341.05 | -336.14 | -427.77 | -570.88 | -453.7 |
Other Financing Activities | 56.72 | 56.62 | 50.11 | 9.74 | -40 | 50 |
Financing Cash Flow | -516.92 | -374.56 | -208.31 | -361.57 | -682.78 | -319.89 |
Foreign Exchange Rate Adjustments | 0.04 | -0.09 | 1.06 | 0.86 | 8.31 | -2.71 |
Net Cash Flow | -332.03 | -95.74 | 31.68 | 94.32 | -226.04 | -59.33 |
Free Cash Flow | 584.84 | 621.18 | 506.16 | 472.85 | 466.4 | 266.15 |
Free Cash Flow Growth | 12.56% | 22.72% | 7.04% | 1.38% | 75.24% | -32.19% |
Free Cash Flow Margin | 27.79% | 30.36% | 23.07% | 21.77% | 23.80% | 15.29% |
Free Cash Flow Per Share | 0.99 | 1.06 | 0.86 | 0.81 | 0.79 | 0.47 |
Cash Income Tax Paid | 342.09 | 339.79 | 334.58 | 389.12 | 251.67 | 247.99 |
Levered Free Cash Flow | 458.37 | 502.03 | 294.68 | 349.37 | 249.38 | 156.13 |
Unlevered Free Cash Flow | 468.55 | 514.44 | 303.33 | 359.59 | 262.03 | 167.51 |
Change in Working Capital | 133.98 | 133.98 | -2.53 | -5.28 | 98.6 | -48.77 |